Johnson & Johnson has completed enrolment in its phase 2b trial of its preventive HIV vaccine, setting up a readout from the much-anticipated study in 2021.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,